153 related articles for article (PubMed ID: 32178718)
21. Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
Pan ZX; Zhang XY; Chen SR; Li CZ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3645-3653. PubMed ID: 31114989
[TBL] [Abstract][Full Text] [Related]
22. MBD family proteins: reading the epigenetic code.
Fatemi M; Wade PA
J Cell Sci; 2006 Aug; 119(Pt 15):3033-7. PubMed ID: 16868031
[TBL] [Abstract][Full Text] [Related]
23. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
Jiang CL; Jin SG; Pfeifer GP
J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
[TBL] [Abstract][Full Text] [Related]
24. Poly(ADP-ribosyl)ation of Methyl CpG Binding Domain Protein 2 Regulates Chromatin Structure.
Becker A; Zhang P; Allmann L; Meilinger D; Bertulat B; Eck D; Hofstaetter M; Bartolomei G; Hottiger MO; Schreiber V; Leonhardt H; Cardoso MC
J Biol Chem; 2016 Mar; 291(10):4873-81. PubMed ID: 26772194
[TBL] [Abstract][Full Text] [Related]
25. Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program.
Pedretti A; Granito C; Mazzolari A; Vistoli G
Mol Inform; 2016 Sep; 35(8-9):424-33. PubMed ID: 27546046
[TBL] [Abstract][Full Text] [Related]
26. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
Auriol E; Billard LM; Magdinier F; Dante R
Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
[TBL] [Abstract][Full Text] [Related]
27. Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2.
Rajavelu A; Lungu C; Emperle M; Dukatz M; Bröhm A; Broche J; Hanelt I; Parsa E; Schiffers S; Karnik R; Meissner A; Carell T; Rathert P; Jurkowska RZ; Jeltsch A
Nucleic Acids Res; 2018 Sep; 46(17):9044-9056. PubMed ID: 30102379
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells.
Hainer SJ; McCannell KN; Yu J; Ee LS; Zhu LJ; Rando OJ; Fazzio TG
Elife; 2016 Nov; 5():. PubMed ID: 27849519
[TBL] [Abstract][Full Text] [Related]
29. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions.
Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N
Elife; 2019 Dec; 8():. PubMed ID: 31868585
[TBL] [Abstract][Full Text] [Related]
30. Methyl-CpG-binding proteins. Targeting specific gene repression.
Ballestar E; Wolffe AP
Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
[TBL] [Abstract][Full Text] [Related]
31. MeCP2 binding to DNA depends upon hydration at methyl-CpG.
Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD
Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390
[TBL] [Abstract][Full Text] [Related]
32. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
33. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
Yu F; Zingler N; Schumann G; Strätling WH
Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
[TBL] [Abstract][Full Text] [Related]
34. L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and repressed by methyl-CpG binding proteins.
Zhang P; Ludwig AK; Hastert FD; Rausch C; Lehmkuhl A; Hellmann I; Smets M; Leonhardt H; Cardoso MC
Nucleus; 2017 Sep; 8(5):548-562. PubMed ID: 28524723
[TBL] [Abstract][Full Text] [Related]
35. Biophysical characterization of the basic cluster in the transcription repression domain of human MeCP2 with AT-rich DNA.
Mushtaq AU; Lee Y; Hwang E; Bang JK; Hong E; Byun Y; Song JJ; Jeon YH
Biochem Biophys Res Commun; 2018 Jan; 495(1):145-150. PubMed ID: 29101034
[TBL] [Abstract][Full Text] [Related]
36. Control of the DNA methylation system component MBD2 by protein arginine methylation.
Tan CP; Nakielny S
Mol Cell Biol; 2006 Oct; 26(19):7224-35. PubMed ID: 16980624
[TBL] [Abstract][Full Text] [Related]
37. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
Nan X; Meehan RR; Bird A
Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
[TBL] [Abstract][Full Text] [Related]
38. Ethanol deregulates Mecp2/MeCP2 in differentiating neural stem cells via interplay between 5-methylcytosine and 5-hydroxymethylcytosine at the Mecp2 regulatory elements.
Liyanage VR; Zachariah RM; Davie JR; Rastegar M
Exp Neurol; 2015 Mar; 265():102-17. PubMed ID: 25620416
[TBL] [Abstract][Full Text] [Related]
39. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
40. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
